Richmond, CA, United States of America

Quian-Jin Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Tapimmune Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quian-Jin Zhang. Retrieved from https://idiyas.com/inventor/quian-jin-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Quian-Jin Zhang

Introduction

Quian-Jin Zhang, an esteemed inventor based in Richmond, CA, has made significant contributions to the field of immunology. With a focus on vaccine development, his work aims to combat viral infections, particularly those affecting mammals, including humans.

Latest Patents

Zhang holds a patent for a groundbreaking vaccine composition designed to enhance the immune response against viral infections. This composition incorporates TAP-1 and/or TAP-2 to improve the antigen processing capabilities of infected cells. By augmenting their immunogenicity, it serves as a potential adjuvant in pox antigen-based vaccines, with notable applications in treating or preventing infections such as smallpox.

Career Highlights

Currently, Quian-Jin Zhang is associated with Tapimmune Inc., where he applies his expertise in vaccine innovation. His singular patent reflects both his commitment to public health and his pioneering spirit in the biotechnology sector.

Collaborations

Throughout his career, Zhang has collaborated with respected colleagues, including Wilfred A. Jefferies and Timothy Z. Vitalis. These partnerships have been instrumental in advancing his research and contributing to his innovative vaccine development endeavors.

Conclusion

Quian-Jin Zhang exemplifies the spirit of innovation within the realm of immunology. Through his patent and collaborative efforts, he continues to pave the way for advancements in vaccine technology, ultimately working towards the betterment of global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…